Google’s DeepMind, UK’s NHS Criticized for Sharing Data

Two reports raise concerns about privacy and proper consent during a controversial data-sharing agreement, but find that only the National Health Service broke the law.

Written byDiana Kwon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, PHOTOBYLOVELast year, New Scientist revealed that DeepMind Health (DMH), a London-based, Google-owned artificial intelligence (AI) company, had access to the health records of 1.6 million patients, and had received them without proper consent.

This occurred through a data-sharing agreement the company made with the Royal Free NHS (National Health Service) Foundation Trust to test and develop an app called Streams, which monitors patients with kidney disease.

In a report released Monday (July 3), the Information Commissioner’s Office (ICO), an independent body in the U.K. set up to uphold information rights, found that the Trust breached the Data Protection Act when it provided Google with patients’ information. The ICO also noted that there were several issues with how data were handled, such as the lack of proper informed consent.

“Patients would not have reasonably expected their information to have been used in this way, and the Trust could and should have been far more transparent with patients as to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA